BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

839 related articles for article (PubMed ID: 18097455)

  • 81. Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis.
    Ettinger DS
    Semin Oncol; 1995 Aug; 22(4 Suppl 10):6-18. PubMed ID: 7570053
    [No Abstract]   [Full Text] [Related]  

  • 82. Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.
    Nolte MJ; Berkery R; Pizzo B; Baltzer L; Grossano D; Lucarelli CD; Kris MG
    J Clin Oncol; 1998 Feb; 16(2):771-8. PubMed ID: 9469369
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer.
    Glare P; Pereira G; Kristjanson LJ; Stockler M; Tattersall M
    Support Care Cancer; 2004 Jun; 12(6):432-40. PubMed ID: 15108099
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.
    Antonarakis ES; Hain RD
    Arch Dis Child; 2004 Sep; 89(9):877-80. PubMed ID: 15321871
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Multidisciplinary oncology panel develops international antiemetic consensus guidelines.
    Clark-Snow R; Rittenberg CN
    ONS News; 2005 May; 20(5):10. PubMed ID: 15918646
    [No Abstract]   [Full Text] [Related]  

  • 86. Practical management of chemotherapy-induced nausea and vomiting.
    Wiser W; Berger A
    Oncology (Williston Park); 2005 Apr; 19(5):637-45. PubMed ID: 15945344
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Management of chemotherapy-induced nausea and emesis.
    Maule WF; Perry MC
    Am Fam Physician; 1983 Jan; 27(1):226-34. PubMed ID: 6130699
    [No Abstract]   [Full Text] [Related]  

  • 88. Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.
    Abbrederis K; Lorenzen S; Rothling N; Ihbe-Heffinger A; Schuster T; Peschel C; Lordick F
    Onkologie; 2009 Feb; 32(1-2):30-4. PubMed ID: 19209016
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Corticosteroids in the treatment of chemotherapy-induced nausea and vomiting.
    Barbour SY
    J Natl Compr Canc Netw; 2012 Apr; 10(4):493-9. PubMed ID: 22491048
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Low incidence of nausea and vomiting with intravenous opiate analgesia in the ED.
    Paoloni R; Talbot-Stern J
    Am J Emerg Med; 2002 Nov; 20(7):604-8. PubMed ID: 12442238
    [TBL] [Abstract][Full Text] [Related]  

  • 91. 2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting.
    Ruhlmann CH; Jahn F; Jordan K; Dennis K; Maranzano E; Molassiotis A; Roila F; Feyer P
    Support Care Cancer; 2017 Jan; 25(1):309-316. PubMed ID: 27624464
    [TBL] [Abstract][Full Text] [Related]  

  • 92. An audit of chemotherapy-induced nausea and vomiting in children.
    Clinton F; Dowling M; Capra M
    Nurs Child Young People; 2012 Sep; 24(7):18-23. PubMed ID: 23155937
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study.
    Booth CM; Clemons M; Dranitsaris G; Joy A; Young S; Callaghan W; Trudeau M; Petrella T
    J Support Oncol; 2007 Sep; 5(8):374-80. PubMed ID: 17944146
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Corticosteroids and lorazepam as antiemetics in cancer chemotherapy.
    Drug Ther Bull; 1986 Jun; 24(12):46-8. PubMed ID: 3720551
    [No Abstract]   [Full Text] [Related]  

  • 95. Antiemetic guidelines: are they being used?
    Kaiser R
    Lancet Oncol; 2005 Aug; 6(8):622-5. PubMed ID: 16054573
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Efficacy of aprepitant in management of chemotherapy-induced nausea and vomiting.
    Osorio-Sanchez JA; Karapetis C; Koczwara B
    Intern Med J; 2007 Apr; 37(4):247-50. PubMed ID: 17388865
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.
    Hesketh PJ; Kris MG; Basch E; Bohlke K; Barbour SY; Clark-Snow RA; Danso MA; Dennis K; Dupuis LL; Dusetzina SB; Eng C; Feyer PC; Jordan K; Noonan K; Sparacio D; Somerfield MR; Lyman GH
    J Clin Oncol; 2017 Oct; 35(28):3240-3261. PubMed ID: 28759346
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Chemotherapy-induced nausea and vomiting: an overview and comparison of three consensus guidelines.
    Tageja N; Groninger H
    Postgrad Med J; 2016 Jan; 92(1083):34-40. PubMed ID: 26561590
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [ECCO 2005. Advances in the prevention of chemotherapy-induced nausea and vomiting].
    Longo F; Mansueto G; Magnolfi E
    Tumori; 2006; 92(1):suppl 24-31. PubMed ID: 16683393
    [No Abstract]   [Full Text] [Related]  

  • 100. Evolving roles of oncology pharmacists in Singapore: a survey on prescribing patterns of antiemetics for chemotherapy induced nausea and vomiting (CINV) at a cancer centre.
    Chan A; Shih V; Chew L
    J Oncol Pharm Pract; 2008 Mar; 14(1):23-9. PubMed ID: 18337437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.